SCHEMBL487286

SCHEMBL487286

CCCCCCCCC(CCCC(=O)OC)C(=O)OC

nearest known ligand 0.58

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
CA2 P00918 3/20 0.58
CA1 P00915 1/20 0.58
ZDHHC7 Q9NXF8 1/20 0.54
LMNA P02545 4/20 0.49
USP2 O75604 1/20 0.49
DGKA P23743 1/20 0.47
TSHR P16473 1/20 0.47
PPARG P37231 1/20 0.46
BIRC2 Q13490 2/20 0.46
L3MBTL1 Q9Y468 1/20 0.45
CA12 O43570 1/20 0.45
CA7 P43166 1/20 0.45
CA9 Q16790 1/20 0.45
CA14 Q9ULX7 1/20 0.45
MAPT P10636 1/20 0.45
POLB P06746 1/20 0.44
POLA1 P09884 1/20 0.44
ALDH1A1 P00352 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28273234 1.00 CA2 (0.58) CA2CA1ZDHHC7LMNAUSP2
SCHEMBL6895660 0.97 CA1 (0.58) CA2CA1ZDHHC7LMNAUSP2
SCHEMBL5978900 0.93 CA2 (0.62) CA2CA1ZDHHC7LMNAUSP2
SCHEMBL28154687 0.93 CA2 (0.67) CA2CA1ZDHHC7LMNAUSP2
SCHEMBL27966661 0.91 CA2 (0.65) CA2CA1ZDHHC7LMNAUSP2
SCHEMBL11615218 0.91 TSHR (0.56) CA2CA1ZDHHC7LMNAUSP2
SCHEMBL27766641 0.90 CA1 (0.54) CA2CA1ZDHHC7LMNAUSP2
SCHEMBL27766650 0.90 CA1 (0.54) CA2CA1ZDHHC7LMNAUSP2
SCHEMBL9506213 0.89 CA1 (0.56) CA2CA1ZDHHC7LMNAUSP2
SCHEMBL18597131 0.89 CA2 (0.70) CA2CA1ZDHHC7LMNAUSP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1178031-B1 PROCESS FOR THE PREPARATION OF ORGANIC COMPOUNDS WITH MANGANESE CATALYSTS OR THE LIKE DAICEL CHEM (JP) 2012-02-01 EP disclosed
US-6548713-B2 Efficiently producing a compound having an alkyl group or alkenyl group bonded at the alpha position of an electron attractive group, by catalytic radical addition reaction with compound of Group 5,6,7,8, or 9 DAICEL CHEMICAL INDUSTRIES, LTD. (JP) 2003-04-15 US disclosed
US-20020165416-A1 Process for the preparation of organic compounds with manganese cataylsts or the like DAICEL CHEMICAL INDUSTRIES, LTD. (JP) 2002-11-07 US disclosed
EP-1178031-A1 PROCESS FOR THE PREPARATION OF ORGANIC COMPOUNDS WITH MANGANESE CATALYSTS OR THE LIKE Daicel Chemical Industries, Ltd. (JP) 2002-02-06 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020165416-A1 Process for the preparation of organic compounds with manganese cataylsts or the like SOD1, CAT, SOD3 CA2 512/4885CA1 1250/4885ZDHHC7 1552/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.